Hunter Associates Investment Management LLC Amgen Inc Transaction History

Hunter Associates Investment Management LLC

$646 Million
Q3 2024

A detailed history of Hunter Associates Investment Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Hunter Associates Investment Management LLC holds 53,998 shares of AMGN stock, worth $15.1 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares

53,998

Previous 54,186 0.35%

Holding current value

$15.1 Million

Previous $16.9 Million 2.74%

% of portfolio

2.69%

Previous 2.85%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $58,163 - $63,427	-188 Reduced 0.35%	53,998 $17.4 Million
Q2 2024 Aug 01, 2024	SELL	$262.75 - $319.31 $198,901 - $241,717	-757 Reduced 1.38%	54,186 $16.9 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $79,854 - $96,394	-297 Reduced 0.54%	54,943 $15.6 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $236,266 - $266,537	-924 Reduced 1.65%	55,240 $15.9 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $170,328 - $211,467	779 Added 1.41%	56,164 $15.1 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $7,285 - $8,614	34 Added 0.06%	55,385 $12.3 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $1,580 - $1,926	7 Added 0.01%	55,351 $13.4 Million
Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $259,490 - $329,714	-1,133 Reduced 2.01%	55,344 $14.5 Million
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $34,117 - $38,478	152 Added 0.27%	56,477 $12.7 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $3.29 Million - $3.66 Million	14,270 Added 33.93%	56,325 $13.7 Million
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $71,262 - $78,835	-325 Reduced 0.77%	42,055 $10.2 Million
Q4 2021 Jan 27, 2022	BUY	$198.88 - $227.6 $159,104 - $182,080	800 Added 1.92%	42,380 $9.53 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $990,239 - $1.16 Million	-4,665 Reduced 10.09%	41,580 $8.84 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $3.35 Million - $3.71 Million	-14,324 Reduced 23.65%	46,245 $11.3 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $107,404 - $125,162	484 Added 0.81%	60,569 $15.1 Million
Q4 2020 Jan 29, 2021	BUY	$216.38 - $257.67 $9,304 - $11,079	43 Added 0.07%	60,085 $13.8 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $46,930 - $52,190	-200 Reduced 0.33%	60,042 $15.3 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $43,913 - $53,888	222 Added 0.37%	60,242 $14.2 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $38,270 - $50,757	210 Added 0.35%	60,020 $12.2 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $157,801 - $202,828	-834 Reduced 1.38%	59,810 $14.4 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $76,608 - $91,792	-440 Reduced 0.72%	60,644 $11.7 Million
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $171,701 - $201,272	-1,030 Reduced 1.66%	61,084 $11.3 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $98,120 - $114,537	-550 Reduced 0.88%	62,114 $12.1 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $97,277 - $109,667	525 Added 0.84%	62,664 $13 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $222,507 - $249,923	-1,340 Reduced 2.11%	62,139 $11.5 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $229,577 - $268,290	-1,355 Reduced 2.09%	63,479 $10.8 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $16,943 - $19,800	-100 Reduced 0.15%	64,834 $11.3 Million
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $1.08 Million - $1.2 Million	6,376 Added 10.89%	64,934 $11.3 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $9.8 Million - $11.2 Million	58,558	58,558 $10.9 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Associates Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Associates Investment Management LLC with notifications on news.

Account

Hunter Associates Investment Management LLC Amgen Inc Transaction History